2,4-diaminoquinazoline has been researched along with Lung Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cheng, M; Guo, J; Hao, C; Pang, Y; Wang, J; Wang, K; Wu, T; Yin, W; Zhao, D; Zhu, M | 1 |
1 other study(ies) available for 2,4-diaminoquinazoline and Lung Neoplasms
Article | Year |
---|---|
Discovery of 2-(4-Substituted-piperidin/piperazine-1-yl)-N-(5-cyclopropyl-1H-pyrazol-3-yl)-quinazoline-2,4-diamines as PAK4 Inhibitors with Potent A549 Cell Proliferation, Migration, and Invasion Inhibition Activity.
Topics: A549 Cells; Cell Movement; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Neoplasm Invasiveness; p21-Activated Kinases; Quinazolines | 2018 |